brain waves image

Output Catalog

ASAP is committed to accelerating the pace of discovery and informing a path to a cure for Parkinson’s disease through collaboration, research-enabling resources, and data sharing. We’ve created this catalog to showcase the research outputs and tools developed by ASAP-funded programs.

  results for ""
Sort
  • Output Type
  • Program
  • CRN Team Name
  • Theme

Cholesterol-mediated Lysosomal Dysfunction in APOE4 Astrocytes Promotes α-Synuclein Pathology in Human Brain Tissue

Development of a 3D model mimicking human brain tissue to investigate neurodegenerative diseases. It found that APOE4 increases α-Synuclein aggregation, linking astrocytes, cholesterol, and protein inclusions, offering potential therapeutic…

Program: Collaborative Research Network
View Article

TNF-NF-κB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons

The ASAP-related findings are the DA neuron purification strategy developed (CD49e-/CD184+) developed and validated in this manuscript, which is suitable for PD-iPSC based disease modeling and DA-neuron related CRISPR screens from our consortium.

Program: Collaborative Research Network
Team:
View Article

Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions

The authors developed an iPSC toolbox utilizing piggyBac-based or targeted transgenes to rapidly induce CNS cells with concomitant expression of aggregation-prone proteins.

Program: Collaborative Research Network
View Article

The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability

The paper describes the ability of alpha-synuclein to bind to P-bodies, machinery that regulates the expression of our genes through mRNAs. When alpha-synuclein abnormally accumulates, the physiologic structure and functions of the P-body are lost.

Program: Collaborative Research Network
View Article

The SATB1-MIR22-GBA axis mediates glucocerebroside accumulation inducing a cellular senescence-like phenotype in dopaminergic neurons

Study shows SATB1, MIR22HG, and GBA genes form a pathway in Parkinson's Disease. Dysregulation leads to GluCer accumulation, causing cellular senescence in dopaminergic neurons, potentially explaining neuroinflammation seen in PD and aging.

Program: Collaborative Research Network
Team:
View Article

Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies

The authors study patients based on protein aggregation phenotype to detect variants in a targeted set of genes.

Program: Collaborative Research Network
View Article

Integrating population genetics, stem cell biology and cellular genomics to study complex human diseases

This review describes current state-of-the art of pooled "village-style" hPSC-based assays. This is a major topic for disease modeling including PD and for linking disease with genetic and/or environmental risk and part of our experimental ASAP work.

Program: Collaborative Research Network
Team:
View Article

Contextual AI models for single-cell protein biology

This study describes PINNACLE a deep learning approach establish context dependent networks. PINNACLE is a key algorithm used in our ASAP project to provide cell type , age-or disease context to our experimental datasets.

Program: Collaborative Research Network
Team:
View Article

Genome-wide CRISPR screen identifies neddylation as a regulator of neuronal aging and AD neurodegeneration.

We found that neddylation-inhibition triggers age-related features in PSC-derived neurons for modeling AD or PD. This strategy can induce late-onset phenotypes including degeneration when applied to DA neurons from PD- versus isogenic control PSCs.

Program: Collaborative Research Network
Team:
View Article

SARS-CoV-2 infection causes dopaminergic neuron senescence.

The ASAP-supported aspect of this study involves the DA neuron senescence work, and experiments using ASAP lines (isogenic a-SYN triplication) to assess interaction of genetic vulnerability with viral-induced senescence as PD penetrance factor.

Program: Collaborative Research Network
Team:
View Article

Immune stimulation of human induced pluripotent stem cells (hiPSC)-derived glia with lipopolysaccharide (LPS)

hiPSCs are used to model human development and diseases. Lipopolysaccharide activates immune cells and triggers cytokine secretion. LPS activates toll-like receptor 4 and NFkB. Protocol how to use LPS to activate iPSC-derived microglia.

Program: Collaborative Research Network
Team:
View Protocol

Available ASAP-related hPSC collection from Team Studer

Collection of human pluripotent stem cell lines consisting of isogenic GBA, LRRK2, SNCA series, KI-reporter lines for TOMM20, b-actin, LAMB1, LAMP1, a-synuclein overexpression lines, and other hPSC resources.

Program: Collaborative Research Network
Team:
View Lab Material

Poly-ornithine/laminin substrate for neural cell culture V.2

Protocol to generate a sticky substrate for neurons.

Program: Collaborative Research Network
Team:
View Protocol

hPSC Passaging and Propagation on laminin521 V.1

Highly efficient passaging and propagation of human PSC.

Program: Collaborative Research Network
Team:
View Protocol

Seeded amplification assay (SAA) from neuronal cell lysates

Seeded amplification assay (SAA) from neuronal cell lysates

Program: Collaborative Research Network
Team:
View Protocol